Who invested in PeLeMed?
PeLeMed's investors include B Capital.
Who invested in PeLeMed
Funding summaryUpdated 26 Oct 2026
$4.2Mraised across 1 round since 2023, from 1 source
- Latest round
- Series A, $4.2MMar 2023
- Investors
- 1
The rounds
- Mar 2023
Founders and team
From PeLeMed's own website: 5 on the team.
- Yong-Chul KimCEO/CTO
- Soo Yeon JangCEO
- Jong Hyeok ParkCFO
- Miran MoonExecutive Director, Global Clinical Development and Strategy
- Soo Jin KimExecutive Director, Global innovative Drug Discovery & Development
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists PeLeMed as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about PeLeMed
How much has PeLeMed raised?
PeLeMed has raised $4.2M across 1 round since 2023.
When did PeLeMed last raise?
PeLeMed's most recent round was a Series A of $4.2M in Mar 2023.
What was PeLeMed's biggest round?
Its most recent round, $4.2M in Mar 2023, is also its largest on record.
Who backed PeLeMed first?
PeLeMed's first round on record, in Mar 2023, was backed by B Capital.
What stage is PeLeMed at?
PeLeMed's latest named round is a Series A, in Mar 2023.
Companies like PeLeMed
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.